The current COVID-19 pandemic has taken the world of HCP marketing and turned it upside down. Biopharma has had to make instantaneous decisions on how to market in this new environment, who to market to, which tactics to significantly increase, and which tactics to walk away from-all with no historical playbook.
Pharma and biotech marketers are facing more challenges than ever in communicating brand messages to target healthcare professionals (HCPs).